Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

B Original: B Cells, Non-Invasive Biomarkers & More

Jason Liebowitz, MD, FACR  |  Issue: August 2025  |  July 15, 2025

In another surprise that challenges the conventional approach to lupus nephritis, Dr. Fava and colleagues have discovered that granulocytes are abundant in the kidneys of patients with lupus nephritis, including in pure membranous disease (i.e., class V lupus nephritis in the ISN/RPS classification system). However, he cautioned attendees not to be fooled by the absence of these cells on the average renal biopsy. Unlike typical neutrophils, those cells seen in patients with lupus nephritis are mostly unilobate and may be missed by traditional histology because they appear to localize most to the tubulointerstitium and may also appear within areas of fibrosis.

In Sum

The lectures provided by all three speakers were captivating to an audience willing think beyond B cells. (Note: As an aside, Dr. Fava’s recent New England Journal of Medicine editorial titled, “To B or Not to B—the Role of B-Cell Depletion in Lupus Nephritis” is a must-read on this broader topic).6

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

For a disease as complex as lupus, it is important to consider the many parts of the immune system that may play a role.


Jason Liebowitz, MD, FACR, is an assistant professor of medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons, New York.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Zeidi M, Kim HJ, Werth VP. Increased myeloid dendritic cells and TNF-α expression predicts poor response to hydroxychloroquine in cutaneous lupus erythematosus. J Invest Dermatol. 2019 Feb;139(2):324–332.
  2. Skopelja-Gardner S, Tai J, Sun X, et al. Acute skin exposure to ultraviolet light triggers neutrophil-mediated kidney inflammation. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2019097118.
  3. Caielli S, Cardenas J, de Jesus AA, et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell. 2021 Aug 19;184(17):4464–4479.e19.
  4. Parikh SV, Almaani S, Brodsky S, et al. Update on lupus nephritis: Core curriculum 2020. Am J Kidney Dis. 2020 Aug;76(2):265–281.
  5. Fava A, Buyon J, Magder L, et al. Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis. JCI Insight. 2024 Jan 23;9(2):e172569.
  6. Fava A. To B or not to B—the role of B-cell depletion in lupus nephritis. N Engl J Med. 2025 Apr 17;392(15):1545–1547.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:B cellsEULAR 2025Lupus nephritismitochondriaskinSLESLE Resource Centersystemic lupus erythematosus (SLE)

Related Articles

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    Systemic Lupus Erythematosus: A Complex, Multi-Challenging Disease

    November 26, 2024

    Reviewing the research presented at ACR Convergence 2024.

    Is B a Key to Autoimmune Therapy?: B Cell-Targeted Therapies in Autoimmune Disease

    January 1, 2010

    A perspective on B cell–targeted therapies in autoimmune disease

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences